Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL854899 | 0.93 | TSHR (0.71) | TSHRALDH1A1 | |
| SCHEMBL855118 | 0.83 | TSHR (0.65) | TSHRALDH1A1 | |
| SCHEMBL854488 | 0.82 | TSHR (0.56) | TSHRALDH1A1 | |
| SCHEMBL29362800 | 0.79 | ALDH1A1 (0.43) | TSHRALDH1A1 | |
| SCHEMBL335922 | 0.79 | ALDH1A1 (0.43) | TSHRALDH1A1 | |
| SCHEMBL9807348 | 0.77 | TSHR (0.41) | TSHRALDH1A1 | |
| SCHEMBL3956387 | 0.74 | ALDH1A1 (0.41) | TSHRALDH1A1 | |
| SCHEMBL854561 | 0.74 | ALDH1A1 (0.41) | TSHRALDH1A1 | |
| SCHEMBL21861 | 0.73 | TSHR (1.00) | TSHRALDH1A1 | |
| SCHEMBL30354042 | 0.73 | TSHR (1.00) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2433933-B1 | PRODUCTION METHOD OF TRI- OR TETRAHALOGEN-SUBSTITUTED PHTHALIDE | SUMITOMO CHEMICAL CO (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-8604221-B2 | Production method of halogen-substituted phthalide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-12-10 | — | — | US | disclosed |
| US-20120142946-A1 | PRODUCTION METHOD OF HALOGEN-SUBSTITUTED PHTHALIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2433933-A1 | PRODUCTION METHOD OF HALOGEN-SUBSTITUTED PHTHALIDE | Sumitomo Chemical Company, Limited (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-20080305082-A1 | 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof | NOVACEA, INC. | 2008-12-11 | — | — | US | disclosed |
| US-20080305082-A1 | 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof | NOVACEA, INC. | 2008-12-11 | — | — | US | disclosed |
| WO-2008103320-A1 | METHODS OF TREATING OPHTHALMIC DISORDERS WITH ANTHRAQUINONES | NOVACEA, INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| EP-0242169-B1 | DIVINYL COMPOUNDS AND CHROMOGENIC RECORDING MATERIAL PREPARED BY USE THEREOF | YAMADA CHEMICAL CO., LTD. (JP) | 1992-01-02 | — | — | EP | disclosed |
| EP-0242170-B1 | DIVINYL COMPOUNDS AND CHROMOGENIC RECORDING-MATERIAL PREPARED BY USE THEREOF | YAMADA CHEMICAL CO., LTD. (JP) | 1991-09-18 | — | — | EP | disclosed |
| US-4835291-A | Divinyl compounds and chromogenic recording-material prepared by using thereof | YAMADA CHEMICAL CO., LTD. (JP) | 1989-05-30 | — | — | US | disclosed |
| US-4808567-A | PHOTOSTABILITY, WATERPROOFING | YAMADA CHEMICAL CO., LTD. (JP) | 1989-02-28 | — | — | US | disclosed |
| EP-0242169-A2 | Divinyl compounds and chromogenic recording material prepared by use thereof | YAMADA CHEMICAL CO., LTD. (JP) | 1987-10-21 | — | — | EP | disclosed |
| EP-0242170-A2 | Divinyl compounds and chromogenic recording-material prepared by use thereof | YAMADA CHEMICAL CO., LTD. (JP) | 1987-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305082-A1 | 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof | RB1, BRCA1, CCNA1 | TSHR 2635/4885ALDH1A1 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.